GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dishman Carbogen Amics Ltd (NSE:DCAL) » Definitions » Stock Based Compensation

Dishman Carbogen Amics (NSE:DCAL) Stock Based Compensation : ₹0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Dishman Carbogen Amics Stock Based Compensation?

Dishman Carbogen Amics's Stock Based Compensation for the three months ended in Dec. 2023 was ₹0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0 Mil.


Dishman Carbogen Amics Stock Based Compensation Historical Data

The historical data trend for Dishman Carbogen Amics's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dishman Carbogen Amics Stock Based Compensation Chart

Dishman Carbogen Amics Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Dishman Carbogen Amics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Dishman Carbogen Amics Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.


Dishman Carbogen Amics Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Dishman Carbogen Amics's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Dishman Carbogen Amics (NSE:DCAL) Business Description

Traded in Other Exchanges
Address
Iscon-Bopal Road, Dishman Corporate House, Ambli, Ahmedabad, GJ, IND, 380 058
Dishman Carbogen Amics Ltd is a biotechnology company that provides contract research and manufacturing services for pharmaceutical companies. It manufactures bulk drugs, specialty chemicals, and outsourced goods. Additionally, the company produces vitamins, such as vitamin D2 and vitamin D3, reagents, antiseptics and disinfectants, transfer catalysts, personal-care ingredients, pharma intermediates, and ammonium and phosphonium high-purity solid Quats. The business generates the vast majority of its revenue in India.

Dishman Carbogen Amics (NSE:DCAL) Headlines

No Headlines